Skip to content

Over 50? Join the PREDICTOM Study and Help Advance Brain Health!

Would you like to help us understand how to reduce the risk of developing Alzheimer’s Disease?

Published 14 August 2025

  • Have you recently noticed a decline in your memory performance?

  • Do you have a close relative with dementia or Alzheimer’s disease?

  • Do you have one or more risk factors for dementia, such as high blood pressure, obesity, or diabetes?

  • And you have not been diagnosed with dementia or Alzheimer’s disease?

If you answered YES to these questions, we would like to invite you to participate in our study on the early detection of memory changes.

Further requirements for participation:
  • You are 50 years or older.

  • You have access to the internet and a computer or tablet.

To hear more about participating in the study, please contact the PREDICTOM study team in your country:

Belgium: predictom@vub.be

France: predictom@docteurmemo.fr

Germany: psy-predictom@med.uni-muenchen.de

Norway: protect-norge@sus.no

Spain: predictom@iislafe.es

Switzerland: predictom@unige.ch

United Kingdom: predictom@kcl.ac.uk

Latest news

PREDICTOM Level 2 Clinical Study has started

News

PREDICTOM Level 2 Clinical Study has started

The PREDICTOM is pleased to announce the launch of Level 2 of its international clinical study—an important next step made possible entirely through the generosity, time, and commitment of participants across Europe. The participants' contributions continue to drive forward our shared goal: improving the early detection of Alzheimer’s disease through accessible, reliable, and science-driven tools.

Read more
📢 PREDICTOM Study Progress

News

📢 PREDICTOM Study Progress

Every contribution tells a story—and together, we’re shaping the future of brain health.

Read more
☝️Finger-Prick Blood Test Could Revolutionize Early Alzheimer’s Detection

News

☝️Finger-Prick Blood Test Could Revolutionize Early Alzheimer’s Detection

A single drop of blood may soon help identify Alzheimer’s disease - even before symptoms appear. Researchers from the PREDICTOM study are exploring a simple, cost-effective finger-prick test that measures a breakthrough biomarker called p-Tau217, offering hope for earlier and more accessible screening. The finger-prick test is included in PREDICTOM Level 1 clinical study.

Read more